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Abdominal hernia (AH) encompasses the most prevalent types of hernia: inguinal, umbilical and 
incisional. Notwithstanding current hernia complications represent a low death toll (nearly 0.001 % 
in developed countries), non-reducible hernias are the most severe cases, which require urgent 
surgical intervention due to their life-threatening nature. In a single year, at the United States of 
America, more than 800 thousand surgeries are performed to repair inguinal hernias. Abdominal 
hernia ubiquitous symptoms include pain, which may represent a mild discomfort or even an 
impairing morbidity. Nevertheless, some patients suffer from morbidity in the post-operative period. 
Recurrence was reduced when the application of a propylene mesh replaced primary suture repair 
more than 60 years ago. Surprisingly, currently the most prevalent hernia mesh materials are based 
on petrochemical plastics such as polypropylene, polyester, polystyrene and expanded 
polytetrafluoroethylene. Unfortunately, despite the plethora of commercial hernia meshes, an 
improvement of the hernia meshes is still warranted, since petrochemical materials exhibit a 
deterioration over time which generate complications and recurrence. This project envisages the 
complete replacement of the conventional plastic-based material of hernia meshes by a fully bio-
based material with superior mechanical properties: bacterial nanocellulose (BNC). BNC is 
synthesized by bacteria and is composed of a 3D matrix of 100 % nanofibrils of cellulose, each with 
a diameter ranging between 20 to 100 nm. When BNC producing bacterium are cultured in static 
culture, the BNC is formed as membrane (nanoporous mesh comprising pores of 100 to 300 nm in 
diameter) at the surface of the culture medium and adopts the shape of the available surface. 
Therefore, it is easy to control the membrane surface shape, as well as its thickness, which can be 
controlled by the incubation time (longer incubation time will result in a larger thickness). The 
selection of the most adequate bacterium for the production of the hernia mesh will be performed 
Nevertheless, for a hernia mesh to be viable it requires pores with a specific diameter to allow the 
permeability of leukocytes, fibroblasts, and permit the arrangement of collagen and blood vessels. 
Per se, the BNC mesh does not possess such large specific pores with the required diameter (> 75 
μm), thus it is proposed the design and development of a template to achieve a AH mesh that meets 
the necessary requirements. Furthermore, due to the high complexity of hernia mesh infection, which 
is extremely difficult to adequately treat without removing the mesh, this project envisages the 
functionalization of BNC AH mesh with antimicrobial properties. Two approaches will be considered 
for the BNC AH mesh functionalization, namely: in situ synthesis and adsorption through filtration. 
NPs optimal concentration and functionalization process will be examined and tailored to obtain a 
BNC AH mesh with effective antimicrobial activity and negligible cytotoxicity. According the AH 
implantation site, three different hernia meshes classes are usually applied: low, medium and high 
weight, thus the optimal antimicrobial BNC meshes of each class will be patented to represent a viable 
commercial alternative, by displaying superior mechanical properties, biocompatibility and low 
infection propensity, to considerably improve AH patience overall wellbeing. 
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